View Article

Abstract

Reactive oxygen species (ROS) in the human body are abundant due to the univalence reduction of oxygen (O2) inhalation. These free radicals can cause diseases like diabetes, cancer, cirrhosis, obesity, and cardiovascular disorders. Enzymatic antioxidant barriers like SOD, GPx, and CAT help neutralize ROS. Factors like ultraviolet rays, NADPH stimulation, cigarette smoke, environmental contaminants, and toxic chemicals contribute to ROS overproduction, causing harm to DNA and lipids. Reactive oxygen species (ROS) are linked to various pathological conditions, and synthetic antioxidants can cause adverse health effects, while medicinal plants contain antioxidant components that prevent ROS-related harm. Aim- The study aims to evaluate and compare the free radical scavenging activity of various medicinal plants using spectrophotometers. Plants possess a diverse array of antioxidant components, including phenols, vitamins, terpenoids, and flavonoids, which have high antioxidant potentials. These plant-derived polyphenolic constituents are more effective in vivo than in vitro. Conclusion— Medicinal plants have been effectively used to treat ROS due to their antioxidant potential, which is primarily due to their rich source of phytonutrients and ingredients like phenols, flavonoids, and terpenoids. The antioxidant potentials of many medicinal plants have been studied for their anti-cancer, immunomodulator, hepatoprotective, and hypolipidemic properties. Significant antioxidant activity was demonstrated by the plant extract in a dose-dependent manner. The extract considerably raised (p < 0.05) serum HDL-c levels while significantly decreasing (p < 0.01 or 0.001) serum TC, TG, LDL-c, and VLDL-c levels in hyperlipemic rats fed a high-fat diet. The extract considerably raised (p < 0.05) blood HDL-c levels while significantly decreasing (p < 0.05, p < 0.01, p < 0.001) serum TC, TG, LDLc, and VLDL-c levels in rats with triton-induced hyperlipidemia. At a dose of 300 mg/kg/day, the extract significantly (p < 0.01) reduced AI in both high-fat-induced (1.70 ± 0.25) hyperlipidemic albino rats.

Keywords

antioxidant components, including phenols, vitamins, terpenoids, and flavonoids

Introduction

- Hyperlipidemia, a medical condition involving high blood lipid levels, is a significant risk factor for cardiovascular diseases. It can be genetic or lifestyle-related, and early detection and management through lifestyle modifications and medication can reduce complications. Hyperlipidemia assessment is crucial for identifying individuals at risk of cardiovascular diseases, as it helps in early detection, intervention, and monitoring of lifestyle changes, dietary modifications, and medications to prevent long-term health complications. Coronary arterial diseases, including atherosclerosis and coronary heart disease, are largely caused by elevated cholesterol levels. To reduce these risks, medical chemists are developing new bioactive molecules to lower lipid levels. This review highlights potential biological targets, treatments, and ongoing research in lipid-lowering agents. [1]. High blood lipids are risk factors for cardiovascular disease. Current treatment for hyperlipidemia is based on NCEP's ATP-III guidelines, with statins being the preferred class. However, research raises questions about the effectiveness of these guidelines. New ATP-IV guidelines are expected, raising uncertainty about target levels and treatment strategies. [2] Antioxidant activity is attributed to various mechanisms such as chain initiation prevention, transition metal ion catalyst binding, peroxide decomposition, reductive capacity, and radical scavenging activity. [3]. Hyperlipidemia is a significant risk factor for cardiovascular diseases, including atherosclerosis, ischemic heart disease, and myocardial infarction, due to disorders in lipid metabolism and plasma lipoproteins. [4] Macrophages in atherosclerotic lesions express myeloperoxidase that yields a unique pattern of protein oxidation products. Myeloperoxidase is also pinpointed as a pathway that promotes LDL oxidation. [5] Oxidized LDL can damage endothelial cells and trigger the expression of adhesion molecules like P-selectin and chemotactic factors like monocyte chemoattractant protein-1 and macrophage colony-stimulating factor, leading to the tethering, activation, and attachment of monocytes and T-lymphocytes to the endothelial cells. [6] Ipomoea carnea, a tropical shrub with numerous medicinal properties, has been found to have toxicological effects. Its leaves, flowers, and seeds have been used to isolate polyhydroxylated alkaloids, which could be beneficial for phytotherapy research and drug development. Ipomea carnea leaf extract contains compounds like swainsonine, 2-epi-lentiginosine, and calystegines B1, B2, B3, and C1, used in Ayurvedic, Siddha, and Unani medical systems as a folk remedy. It contains chemical components like 2-ethyl-1,3-dimethylbenzene. [7]  The exposure to higher doses of Ipomoea carnea in rat pups and adult offspring resulted in higher postnatal mortality, smaller size, reversible hyperflexion of carpal joints, delay in opening ears, and negative geotaxis. [8] Ipomoea carnea leaf extracts in mice and rats reduced phenobarbitone-induced sleep time, decreased exploratory activity, prolonged maze time, and increased convulsion onset. The acute toxicity showed an LD50 of 3000 mg/kg, supporting its use in traditional medicine for convulsion and psychosis management. [9]. The cardiac effect of I. carnea's fresh leaves on mouse and frog hearts. The extract blocks the isolated frog heart by a dose-dependent increase in cardiac contractility. Atropine blocks the initial depressant phase and potentiates the stimulant effect. The extract produces a positive inotropic effect on the isolated frog heart, possibly due to sodium extrusion or intracellular calcium release [10].  Cardiovascular function and chemically-induced toxicity [11] Cardiac effect of Ipomoea carnea leaf extract on frog and mouse hearts. It shows that the extract blocks the heart and then increases cardiac contractility. Atropine blocks the initial depressant phase and intensifies the stimulant effect. The extract's effects aren't affected by propranolol or calcium channel blockers [12]. Antioxidants are crucial in lipid studies due to their role in preventing lipid peroxidation, influencing lipid metabolism, evaluating oxidative damage, and assessing therapeutic potential. They help prevent oxidized LDL, which contributes to atherosclerosis and hyperlipidemia. Antioxidants also modulate enzyme activities involved in cholesterol synthesis, transport, and breakdown, helping maintain healthy lipid levels.

Experimental 

Plant material

The medicinal plant samples were collected from Durg, Chhattisgarh, and were identified by Professor Dr. Satyendra Sen, VYT College, Durg. The dried samples were carried out to the Department of Biology, Durg, where the evaluation of the antioxidant properties of the medicinal plant samples was achieved under the supervision of Professor Dr. Bhumika Chandrakar. The chemicals, solvents, and reagents used in the preparation of plant extracts were distilled water, ascorbic acid, DPPH (1, 1-diphenyl, 2-picryl hydrazyl), methanol, and ethanol. The required materials include hydrogen peroxide (40 mm), phosphate buffer (pH 7.4), a sample (antioxidant extract, compound, or standard), and a spectrophotometer set to 230 nm.

Preparation of extracts 

The plant was washed, shade-dried, and powdered in a heavy-duty Willy mill (Bells India Ltd.), and then 500 g of dried powder was soaked in 2500 mL of ethanol. After 15 days, the whole mixture was filtered through cotton wool, and the filtrate was concentrated under reduced pressure using a rotary evaporator method. The yield of extract was 43%. The extract was stored in the refrigerator at 4°C until further use. The extract was dissolved in 1% carboxyl-methyl cellulose used for the animal studies [13]

Preliminary phytochemical screening of ethanolic plant extract

The ethanol extract of Ipomoea carnea underwent preliminary phytochemical screening for alkaloids, glycosides, steroids, coumarin, tannins, flavonoids, saponins, and reducing sugar, using color intensity or precipitate formation as analytical responses. [14]

Experimental animal

The study involved Wistar albino rats aged 8-10 weeks, weighing 120-250 g each, from Rungta Institute of Pharmaceutical Sciences, Bhilai animal house. The rats were kept in clean and dry polypropylene cages with a 12-hour light-dark cycle and a standard laboratory diet. They were fed water ad libitum and were kept in the environment for at least 3-4 days before the experiment. [15] The protocol used for diabetic and antihyperlipidemic research was based on the guidelines of the Institutional Animal Ethics Committee (IAEC). The rats were sensitive to environmental changes and were kept in the same environment for at least 3-4 days before the experiment. Blood samples of Wistar rats were taken on day 29 after administering sweet potato leaves ethanol extract. The rats were fasted for 12 hours before taking the samples. Blood was drawn from the retro-orbital plexus using a capillary tube and centrifuged for 10 minutes at 12,000 RPM. Blood serum was separated for cholesterol, triglyceride, SGOT, and SGPT levels using the Diasys® kit, following the manufacturer's protocol. Five rats per group received oral administration of Ipomoea carnea dissolved in 1% carboxymethyl cellulose at doses ranging from 100 to 2500 mg/kg. Mortality was noted 72 hours later. The Litchfield and Wilcoxon method was used to determine acute toxicity. [16]

Determination of DPPH scavenging activity

The DPPH assay is a widely used method to measure antioxidant capacity, but its measurement requires careful consideration due to the non-linear relationship between antioxidant concentration and antiradical activity. [17]. The increasing use of antioxidants to minimize oxidative stress effects is a growing concern. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay is used to assess the antiradical properties of various compounds. [18]. Three milliliters of a 0.1 mmol/L ethanol solution of DPPH were added to one milliliter of the sample (20, 40, 60, 80, 100, 120, 140 μg/mL). Following a 30-minute incubation period, the absorbance of each sample was measured at 517 nm (Shimmadzu-1800, Japan).

Inhibition of DPPH (D) was determined according to Eq 1.

D (%) = {(Ac – As)/Ac}100 …………………. (1) 

where Ac and As are the absorbance of control and test samples, respectively.

Determination of H?O? scavenging activity

The H?O? assay is a widely used method to measure antioxidant capacity, but its measurement requires careful consideration due to the non-linear relationship between antioxidant concentration and antiradical activity. Hydrogen peroxide is a key redox metabolite involved in redox sensing, signaling, and regulation. Recent research explores its metabolic sources and sinks, its role in redox signaling under physiological conditions, and its potential for assaying in biological settings. It also explores its role in oxidative stress. [19] The assay involves introducing plant extracts to a reaction system involving H?O?, phenol, and 4-aminoantipyrine in the presence of horseradish peroxidase. The assay has been found to be convenient and precise, making it suitable for rapid quantification of the H?O? scavenging ability of standard and natural antioxidants present in plant extracts. [20]]. The increasing use of antioxidants to minimize oxidative stress effects is a growing concern. Three milliliters of a 0.1 mmol/L ethanol solution of H?O? were added to one milliliter of the sample (20, 40, 60, 80, 100, 120, 140 μg/mL). Following a 30-minute incubation period, the absorbance of each sample was measured at 250 nm (Shimmadzu-1800, Japan).

H?O? = {(Ac – As)/Ac}100 …………………. (2) 

Assessment of total flavonoid content

The aluminum chloride method was used to determine the total flavonoid content of sample extracts. Aliquots were mixed with methanol, AlCl? (10%), Na-K tartrate, and distilled water and shaken for 30 minutes. Absorbance at 415 nm was recorded, and a calibration plot was generated using known quercetin concentrations. The concentrations of flavonoid in the samples were calculated from the plot and expressed as mg quercetin equivalent/g of sample. [21]

High-fat-induced hyperlipidemia model

The modified method to produce a high-fat diet induced hyperlipidemia. Normal food pellets were crushed and ground into a fine powder, along with cholesterol, cholic acid, sucrose, and coconut oil. These ingredients were then added to the grinder to create feed balls, which were stored in a refrigerator at 2-8°C. The normal group's feed was prepared by grinding normal food pellets and mixing them with water once every three days. The animals were fed a high-fat diet for 30 days, and their serum blood cholesterol levels were regularly monitored. [22] The animals were fed a high-fat diet for 30 days, and their serum blood cholesterol levels were regularly monitored. [23]

Experimental design for high-fat-induced hyperlipidemic rats

Wistar rats were divided into five groups: normal control, high-fat diet, atorvastatin, plant extract, and 300 mg/kg/day plant extract.

Table 1: High-fat-induced hyperlipidemic rats

Group

Experiment

Received

Group 1

Normal

Only vehicles

Group 2

HFD

HFD

Group 3

Atorvastatin

10 mg Atrovastatin

Group 4

Plant extract

ICEA mg/kg

Group 5

Plant extract

ICEA 300 mg/kg

Group 1: Served as a normal control and were given only vehicle (distilled water).

Group 2: Received a high-fat diet and served as hyperlipidemic control (positive control).

Group 3: Received 10 mg/kg/day atorvastatin served as standard 

Group 4: Received 150 mg/kg/day plant extract 

Group 5: Received 300 mg/kg/day plant extract

Table 2 HFD composition

S.No.

Nutrient

Standard diet

High-fat diet

1

Fat

10-15%

40-60%

2

Protein

15-20%

15-20%

3

Carbohydrate

55-65%

20-40%

4

Cholesterol

0.02%

0.2-2%

After 14 days of treatment, rats were fasted for 15 days, and blood samples were collected by retro-orbital sinus puncture under mild anesthesia. The collected samples were centrifuged for 30 minutes at 2000 rpm, and the serum samples were used for various biochemical tests. The study aimed to understand the effects of different treatments on rats' health. On the 8th day, blood samples were collected through retro-orbital sinus puncture under ether anesthesia and centrifuged for 15 minutes at 2500 rpm. Serum samples were then collected and analyzed for TC, TG, and HDL-c using appropriate kits, and VLDL-c and LDL-c were calculated using Friedewald's relationships. [24]

VLDL-c = (TG)/5 ………….…………………. (2) 

LDL-c = TC - (HDL-c + VLDL-c) ……………… (3)

The atherogenic index was calculated as in Eq 4 (Schulpis’ equation).

Atherogenic index (AI) = (TC – HDL-c)/HDL-c …… (4)[25]

Percentage of SGOT and SGPT activity

The hepatoprotective effect of treatment was evaluated by calculating the percentage of reduction.

according to the formula:

% reduction = value of SGOT/SGPT in negative control – value of SGOT/SGPT in treatment group

Value of SGOT/SGPT in negative control

Histopathological observation

The mice were anesthetized and dissected, and their livers were washed with 0.9% NaCl. Histopathological preparations were made using the Kiernan method, and the liver was sliced, stained, and observed qualitatively using a microscope. [26]. The study aimed to understand liver function.

Statistical data analysis

The data was analyzed using one-way ANOVA and Dunnett's test using SPSS software, with a significance level of p < 0.05.

RESULTS

Phytochemical profile

The extract's phytochemical profile reveals the presence of alkaloids, glycosides, flavonoids, phenols, and amino acids. (Table 3).

Table: Qualitative phytochemical profile of ethanol extract of Ipomea carnea

S. No.

Test

Observation

Result

1

Alkaloid

 

 

 

Mayers test

Cream PPT.

+ve

 

Wagner test

Reddish-brown

+ve

2

Flavonoids

 

 

 

Shinoda

Yellow

+ve

 

Ferric chloride

Green-black ppt

+ve

3

Glycoside

 

 

 

Molisch test

Violet ring formed in between 2 layers

+ve

 

Benedict

Light green

+ve

4

Phenol

 

 

 

Ferric chloride

Greenish black

+ve

 

Lead acetate

Yellow

+ve

5

Amino acid

 

 

 

Ninhydrin

No change

-ve

Acute toxicity

The plant extract was found to be safe up to a dose of 2500 mg/kg of body weight, and the animals' behavior was observed for 8 hours, followed by 8 hours every 8 hours for 72 hours.

DPPH scavenging activity

The ethanol extract of I. carnea showed an increase in DPPH radical scavenging activity with increasing extract concentration, resulting in an odd electron-containing DPPH radical with an absorbance at 515-517 nm and a visible deep purple color. The ethanol extract of I. carnea showed significant antioxidant activity, with an IC50 value of 130.320 µg/mL and 11.24 µg/mL compared to ascorbic acid.

%RSA = (Abs of Control) - (Abs of Sample)/ (Abs of Control) *100

H?O? scavenging activity

The H?O? scavenging assay measures antioxidants' ability to neutralize hydrogen peroxide, a reactive oxygen species that can cause oxidative stress and cell damage. Antioxidants prevent damage to DNA, proteins, and lipids, complementing DPPH for detoxification. The study measures the scavenging activity of a sample by reducing H?O? absorbance at 230 nm using a UV-Vis spectrophotometer.

% radical scavenging and IC50 from H2O2 Assay

%RSA = (Abs of Control) - (Abs of Sample)/ (Abs of Control) *100

Total phenol and flavonoid content

The study investigated the total phenol and flavonoid content of the I. carnea expressed in gallic acid quercetin equivalents. The phenolic content was found to correlate with antioxidant activity investigation correlates with their antioxidant activity (128.016 ± 0.056 mg GAE/g), while the flavonoid content was significant compared to the standard (168.33 ± 0.061 mg QE/g).

Effect of extract carnea on lipid profile

oral administration of  ethanol extract of I. carnea on lipid profile  (150 mg/kg and 300 mg/kg, p.o.) significantly reduced serum TC, TG, LDL-c, and VLDL-c levels in a high-fat diet-induced hyperlipidemia model, but increased HDL-c levels is observed.

Fig. 1: Graphical representation of TC, HDL, TG, VLDL, LDL, and AI determines the spike in HDL and LDL.

Obesity is recognized as a substantial risk factor for certain chronic diseases, including hypertension, cardiovascular disease, and type 2 diabetes [27]. Obesity worldwide is increasing, with dietary fat intake being a significant factor in increasing body weight and lipid profile [28]. The study found that diets high in fat can lead to obesity in both rats and mice in animal models. [29]. Propylthiouracil (PTU), an antithyroid medication, can accelerate body weight increase and lipid formation by reducing the blood's thyroid level, leading to hypothyroidism. This affects lipoprotein metabolism by decreasing LDL receptors, increasing LDL in the blood, and forming cholesterol. [30] [31]. The study found that the use of ICE on rats on a high-fat diet can prevent weight gain due to the accumulation of free fatty acids in the tissue, which can trigger glucose uptake and glycogenesis, leading to increased body mass and hyperlipidemia. The treatment significantly reduced the increase in body weight compared to the negative control. [15]

Table No. 4: protective effect of Ipomoea carnea leaf extract on hepatotoxicity caused by high-fat induction

Groups

reduction of SGOT activity

% reduction of SGPT activity

ICE 100 mg/kg

BW 45.96

41.55

ICE 200 mg/kg

BW 53.65

61.04

ICE 400 mg/kg

BW 70.02

71.44

 

The study found that SPLE treatment significantly inhibited body weight increase compared to a negative control. Leaves, a high-nutritional food with high fiber content, are recommended for their antioxidant activity and polyphenol content, making them a functional food with significant fiber content. [32]

Treatment with SPLE reduce the blood lipid

High-fat feeding for 14 days increased cholesterol and triglyceride levels compared to the normal group. High fat consumption increases acetyl-CoA production, which affects fatty acid formation and synthesis of fat into cholesterol. The saturated fatty acids in HFDs increase LDL levels by lowering LDL receptors in the liver, reducing the disposal of LDL in the blood, and increasing LDL in the blood, leading to an increase in total cholesterol levels. [33]. The study found that a high-fat diet in rats increased triglyceride levels higher than a high-carbohydrate diet, indicating a correlation between cholesterol and triglyceride levels. [34], [35]. The study found that SPLE treatment significantly decreased total cholesterol and triglyceride levels in hyperlipidemic rats, with higher doses causing greater decreases. The treatment of 400 mg/kg BW resulted in a significant decrease in total cholesterol, but still within the normal range of 10-54 mg/dL in Wistar rats. [36]. The treatment with SPLE 400 mg/kg BW resulted in a decrease in triglyceride levels, which was less than the normal range of 26-145 mg/dL. [37]  The antioxidant effect of the high polyphenol content in SPLE is a crucial factor in its effectiveness. [38] Polyphenol inhibits LDL cholesterol oxidation by binding to free radicals and transitioning metal ions, preventing lipid peroxidase. [39]. Lipid peroxidase, involved in fatty acid biosynthesis, can be inhibited by flavonoid-containing SPLE treatment, which also reduces cholesterol absorption, increases bile excretion, and inhibits 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) inhibition. [40]. Flavonoids are known to inhibit lipid peroxidase by affecting the activity of the acyl-coenzyme cholesterol acyltransferase (ACAT), which is involved in cholesterol esterification in the intestine and liver, and the enzyme 3-hydroxy-3-methyl-glutaril-CoA. [41]. The tannin content in SPLE, a phenolic content, can decrease cholesterol and triglyceride levels by inhibiting lipid absorption. This is due to the presence of protein and lipids in the feed, which can be deposited by tannins in the SPLE. [42]

DISCUSSION—Lipids, including cholesterol, triglycerides, and phospholipids, are transported in the blood as lipoproteins, composed of enzymes and apolipoproteins. [45] Antioxidant activity mechanisms like prevention of chain initiation, binding of transition metal ion catalysts, decomposition of peroxides, reductive capacity, and radical scavenging activity. Ipomoea carnea, a traditional plant, highlights its antibacterial, antifungal, antioxidant, anticancer, immunomodulatory, antidiabetic, hepatoprotective, anti-inflammatory, anxiolytic, sedative, and wound-healing activities. The study also discusses major phytochemicals associated with its bioactivity, potentially benefiting phytotherapy research. [46] I. carnea extracts significantly prevented drug-induced hepatic enzyme increase, reduced lipid peroxidation in liver tissue, restored antioxidant enzyme activities, and attenuated hepatocellular necrosis and inflammatory cell infiltration. This supports the traditional use of I. carnea extracts for liver injury protection. [47] Statin-ezetimibe combinations, a fixed-dose combination with atorvastatin, have been approved in several countries for high-risk patients seeking cholesterol reduction. Studies show that combination therapy leads to greater LDL-C reduction and a higher proportion of patients achieving lipid goals, and atorvastatin-ezetimibe combinations are generally well-tolerated. [48] Antioxidant studies show that hyperlipidemic individuals often have high levels of oxidative stress, leading to lipid peroxidation, endothelial dysfunction, and an increased risk of atherosclerosis. High cholesterol levels contribute to oxidized LDL, promoting inflammation and cardiovascular diseases. Antioxidants like vitamin C, vitamin E, polyphenols, flavonoids, and carotenoids can reduce oxidative stress, improve lipid profiles, and protect against atherosclerosis. Supplementation can lower total cholesterol, LDL cholesterol, and triglycerides while increasing HDL cholesterol, contributing to better cardiovascular health. Antioxidant-rich diets and natural compounds show promise in managing hyperlipidemia and reducing cardiovascular complications.

Figure: The histopathological observation of hyperlipidemic rat liver treated with Ipomea carnea leaves extract with various doses: (a) normal, (b) negative control, (c) 100 mg/kg BW, (d) 200 mg/kg BW, (e) 400 mg/kg BW

Table 5. The degree of liver damage of Ipomea carnea leaf extract-treated hyperlipidemic rats

Groups

Degree of cell damage

 

normal

Fatty degeneration

necrosis

1. Normal

+++

_-_

+

2. Negative

+

++

+

3. IPE 100 mg/kg BW

++

+

+

4. IPE 200 mg/kg BW

+++

-

+

5. IPE 400 mg/kg BW

++

+

+

Treatment of SPLE prevents liver damage.

 A high-fat diet can lead to liver dysfunction, specifically fatty liver disease, where fat accumulates in the liver's hepatocytes. [49]. Steatohepatitis is a fatty liver disease that results in fibrosis, cirrhosis, and hepatocellular carcinoma due to an imbalance in the liver's production and secretion of triglycerides. The accumulation of fatty acids in the liver exceeds its oxidative capacity, leading to free radical formation, hepatocyte necrosis, and liver damage. This increases the activity of SGOT and SGPT enzymes, a marker of liver damage. [50]. The liver processes the increased fatty acids in the blood, converting them into triglycerides. This accumulation increases TNF-α and NADPH oxidase, leading to the production of superoxide radicals. These radicals are highly reactive to lipids, causing lipid peroxidation. This leads to changes in liver cell permeability, causing enzymes like serum glutamate pyruvate transferase (SGPT) and serum glutamate oxaloacetate transaminase (SGOT) to increase in the blood.  The study reveals that high-fat feeding induction can increase SGOT and SGPT activity levels due to liver lipid accumulation and the production of free radical species [51]. The study found that treating hyperlipidemic rats with SPLE reduced SGOT and SGPT activity levels significantly. One compound in SPLE, quercetin, has antioxidant properties as a free radical scavenger, protecting the liver from oxidative damage. Quercetin decreases the activity of SGOT and SGPT enzymes, preventing liver damage from oxidative stress and lipid peroxidation. It also acts as a scavenger of reactive oxygen species (ROS) produced by high-fat feeding. [52] Effectiveness of SPLE in protecting liver damage from high-fat induction. SPLE inhibits free radical production, increasing its protective effect with dose. The value of SGPT and SGOT in the SPLE 200 mg/kg BW group did not significantly differ from the normal group. Treatment with 200 mg/kg BW showed the best results in decreasing SGPT and SGOT.

CONCLUSION

The ethanol extract of Ipomoea carnea exhibits potent antioxidant and antihyperlipidemic properties. Medicinal plants have been effectively used to treat ROS due to their antioxidant potential, which is primarily due to their rich source of phytonutrients and ingredients like phenols, flavonoids, and terpenoids. The antioxidant potentials of many medicinal plants have been studied for their anti-cancer, immunomodulator, hepatoprotective, and hypolipidemic properties. Significant antioxidant activity was demonstrated by the plant extract in a dose-dependent manner. The extract considerably raised (p < 0.05) serum HDL-c levels while significantly decreasing (p < 0.01 or 0.001) serum TC, TG, LDL-c, and VLDL-c levels in hyperlipemic rats fed a high-fat diet. The extract considerably raised (p < 0.05) blood HDL-c levels while significantly decreasing (p < 0.05, p < 0.01, p < 0.001) serum TC, TG, LDLc, and VLDL-c levels in rats with triton-induced hyperlipidemia. At a dose of 300 mg/kg/day, the extract significantly (p < 0.01) reduced AI in both high-fat-induced (1.70 ± 0.25) hyperlipidemic albino rats. Low-density lipoprotein (LDL) is a type of cholesterol that can block arteries, causing artery plaque. It ranges from 130 mg/dL to 159 mg/dL, with high numbers reaching 160 to 189 mg/dL. Very low-density lipoprotein (VLDL) is also considered bad due to its triglyceride content. High-density lipoprotein (HDL) is considered good cholesterol as it transports cholesterol to the liver, which removes it, like a tow truck removing broken-down vehicles from traffic lanes. HDL levels should not be lower than 40 mg/dL. "Dysfunctional" and "dysregulated cholesterol" are terms used interchangeably to describe abnormalities in cholesterol levels, such as high or imbalanced levels. High cholesterol and inflammation in normal cholesterol levels increase the risk of heart disease.

REFERENCES

  1. Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. The biology and chemistry of hyperlipidemia. Bioorganic & Medicinal Chemistry. 2007 Jul 15;15(14):4674-99.
  2. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Primary care. 2012 Dec 4;40(1):195.
  3. Kaur G, Alam MS, Jabbar Z, Javed K, Athar M. Evaluation of antioxidant activity of Cassia siamea flowers. J Ethnopharmacol 2006; 108: 340-348
  4. Kaesancini AY, Krauss RM. Cardiovascular disease and hyperlipidemia. Current topics of lipid dynamics 1994; 5: 249-251.
  5. Sharma S, Verma A, Teja BV, Shukla P, Mishra PR. Development of stabilized paclitaxel nanocrystals: in vitro and in vivo efficacy studies. Eur J Pharm Sci 2015; 69: 51-60. 8
  6. Araujo FB, Barbosa DS, Hsin CY, Maranhao RC, Abdalla DS. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis 1995; 117: 61-71.
  7. Haraguchi M, Gorniak SL, Ikeda K, Minami Y, Kato A, Watson AA, Nash RJ, Molyneux RJ, Asano N. Alkaloidal components in the poisonous plant, Ipomoea carnea (Convolvulaceae). Journal of Agricultural and Food Chemistry. 2003 Aug 13;51(17):4995-5000.
  8. Schwarz A, Górniak SL, Bernardi MM, Dagli ML, Spinosa HD. Effects of Ipomoea carnea aqueous fraction intake by dams during pregnancy on the physical and neurobehavioral development of rat offspring. Neurotoxicology and teratology. 2003 Sep 1;25(5):615-26.
  9. Rout SK, Kar DM. Sedative, anxiolytic, and anticonvulsant effects of different extracts from the leaves of Ipomoea carnea in experimental animals. Int J Drug Dev Res. 2013 Apr;5(2):232-43
  10. Bachhav KV, Burande MD, Rangari VD, Mehta JK. Effect of aqueous extract of Ipomoea carnea leaf on isolated frog and mouse hearts.
  11. Partridge CR, Johnson CD, Ramos KS. In vitro models to evaluate acute and chronic injury to the heart and vascular systems. Toxicology in vitro. 2005 Aug 1;19(5):631-44.
  12. Bachhav KV, Burande MD, Rangari VD, Mehta JK. Effect of aqueous extract of Ipomoea carnea leaf on isolated frog and mouse heart
  13. Kumar V, Ahmed D, Gupta PS, Anwar F, Mujeeb M. Antidiabetic, antioxidant, and antihyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin-induced diabetic rats. BMC Complement Altern Med 201; 13: 222.
  14. Sahu K, Kohli S. QUALITATIVE PHYTOCHEMICAL SCREENING OF LEAVES AND STEM OF IPOMOEA CARNEA. European Journal of Biomedical. 2016;3(11):208-11.
  15. Maha AA, Ahmed IY, Sakina MY. Evaluation of antidiabetic activity of plants used in western Sudan. Asian pac J Trop biomed 2015; 5: 395-402
  16. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
  17. Locatelli M, Gindro R, Travaglia F, Coïsson JD, Rinaldi M, Arlorio M. Study of the DPPH-scavenging activity: Development of free software for the correct interpretation of data. Food chemistry. 2009 Jun 1;114(3):889-97
  18. Mishra K, Ojha H, Chaudhury NK. Estimation of antiradical properties of antioxidants using DPPH assay: A critical review and results. Food chemistry. 2012 Feb 15;130(4):1036-43.
  19. . Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox biology. 2017 Apr 1;11:613-9.
  20. Fernando CD, Soysa P. Optimized enzymatic colorimetric assay for determination of hydrogen peroxide (H?O?) scavenging activity of plant extracts. MethodsX. 2015 Jan 1;2:283-91.
  21. Khatiwora E, Adsul VB, Kulkarni MM, Deshpande NR, Kashalkar RV. Spectroscopic determination of total phenol and flavonoid contents of Ipomoea carnea. International Journal of ChemTech Research. 2010 Jul;2(3):1698-701.
  22. Blank B, Pfeiffer FR, Greenberg CM, and Kerwin JF. Thyromimetics II: The synthesis and hypercholesterolemic activity of some b-dimethylaminoethyl esters of thyroalkanoic acids. J Med Chem 1963; 6: 560-563
  23. Pande VV, Dubey S. Antihyperlipidemic activity of Sphaeranthus indicus on atherogenic diet-induced hyperlipidemia in rats. Int J Green Pharm 2009; 3: 159–161.
  24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 197; 18: 499-502
  25. Schulpis K, Karikas GA. Serum cholesterol and triglyceride distribution in 7767 school-aged Greek children. Pediatrics 1998; 101: 861-864.
  26. Z. Kmiec, “J.A. Kiernan. Histological and Histochemical Methods: Theory and Practice. 5th edition, Scion Publishing, 2015, 571 pp.,” Folia Histochem. Cytobiol., vol. 54, no. 1, pp. 58–59, 2016, doi: 10.5603/fhc.a2016.0007.
  27. K. M. Gadde, C. K. Martin, H. R. Berthoud, and S. B. Heymsfield, “Obesity: Pathophysiology and Management,” J. Am. Coll. Cardiol., vol. 71, no. 1, pp. 69–84, 2018, doi: 10.1016/j.jacc.2017.11.011.
  28.  F. Barkas, T. Nomikos, E. Liberopoulos, and D. Panagiotakos, “Diet and cardiovascular disease risk among individuals with familial hypercholesterolemia: Systematic review and meta-analysis,” Nutrients, vol. 12, no. 8, pp. 1–22, 2020, doi: 10.3390/nu12082436.
  29.  S. Parasuraman and L. E. Wen, “Animal Model for Obesity—An Overview,” Syst. Rev. Pharm., vol. 6, no. 1, pp. 9–12, 2015.
  30.  J. H. H. Al-awadi, “Hypothyroidism and High Fat Diet Could Accelerate Obesity and Aggravate Inflammation in Albino Rats,” J. Biol., no. September, pp. 1–14, 2016.
  31.  S. Singh, V. Panda, S. Sudhamani, and P. Dande, “Protective effect of a polyherbal bioactive fraction in propylthiouracil-induced thyroid toxicity in rats by modulation of the hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes,” Toxicol. Reports, vol. 7, no. July 2019, pp. 730–742, 2020, doi: 10.1016/j.toxrep.2020.06.002.
  32. K. Sikder, S. K. Shukla, N. Patel, H. Singh, and K. Rafiq, “High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR-γ,” Cell. Physiol. Biochem., vol. 48, no. 3, pp. 1317–1331, 2018, doi: 10.1159/000492091.
  33.  H. Sun, T. Mu, L. Xi, M. Zhang, and J. Chen, “Sweet potato (Ipomoea batatas L.) leaves as nutritional and functional foods,” Food Chem., vol. 156, pp. 380–389, Aug. 2014, doi: 10.1016/j.foodchem.2014.01.079.
  34. D. F. Coelho et al., “Effect of high-fat diets on body composition, lipid metabolism, and insulin sensitivity, and the role of exercise on these parameters,” Brazilian J. Med. Biol. Res., vol. 44, no. 10, pp. 966–972, Oct. 2011, doi: 10.1590/S0100-879X2011007500107.
  35. M. A. Al Mamun et al., “High carbohydrate high fat diet induced hepatic steatosis and dyslipidemia were ameliorated by psidium guajava leaf powder supplementation in rats,” Evidence-based Complement. Altern. Med., vol. 2019, pp. 1–12, 2019, doi: 10.1155/2019/1897237.
  36.  C. Artha, A. Mustika, and S. W. Sulistyawati, “Singawalang Leaf Extract Effects on LDL Levels of Hypercholesterolemic Male Rats,” e-Journal Kedokt. Indones., vol. 5, no. 2, pp. 105–109, 2017.
  37. Xie JH, Jin ML, Morris GA, Zha XQ, Chen HQ, Yi Y, Li JE, Wang ZJ, Gao J, Nie SP, Shang P, Xie MY. Advances on Bioactive Polysaccharides from Medicinal Plants. Crit Rev Food Sci Nutr. 2016 Jul 29;56 Suppl 1:S60-84. doi: 10.1080/10408398.2015.1069255. PMID: 26463231.
  38. N. Mahfudh and N. Ikarini, “In vivo effect of sub-chronic administration of ethanol extract of Rosella (Hibiscus sabdariffa L.) calyx on total blood cholesterol, triglyceride level, and heart histopathologic profile,” Int. Food Res. J., vol. 25, no. 3, pp. 1253–1257, 2018.
  39.  S. Hue, A. N. Boyce, and C. Somasundram, “Comparative Study on the Antioxidant Activity of Leaf Extract and Carotenoids Extract from Ipomoea batatas var. Oren (Sweetpotato) Leaves,” Int. J. Nutr. Food Eng., vol. 5, no. 10, pp. 604–607, 2011.
  40.  R. N. I. Siregar, “The Effect of Eugenia polyantha Extract on LDL,” J. Major., vol. 4, no. 5, pp. 85–92, 2015.
  41.  F. D. Lairin, D. Lyrawati, and S. Soeharto, “Ekstrak Daging Putih Semangka (Citrulus vulgaris) Menurunkan Kolesterol Total dan Aktivitas Hidroksi-Metilglutaril-KoA Reduktase Tikus Hiperkolesterolemia,” J. Kedokt. Brawijaya, vol. 29, no. 2, pp. 104–109, 2016, doi: 10.21776/ub.jkb.2016.029.02.2.
  42. A. G. Elfadhl, M. K. Sabahelkhier, M. Y. Rayan, M. O. Daa, A. H. Nagla, and S. B. Israa, “Effect of Tannin and Plant Tannins on Some Organs and Physic-Chemical Characters of Diabetic Wistar,” Int. J. Adv. Res., vol. 1, no. 10, pp. 165–170, 2013.
  43.  D. Kumar, D. K. Dwivedi, M. Lahkar, and A. Jangra, “Hepatoprotective potential of 7,8-Dihydroxyflavone against alcohol and high-fat diet induced liver toxicity via attenuation of oxido-nitrosative stress and NF-κB activation,” Pharmacol. Reports, vol. 71, no. 6, pp. 1235–1243, Dec. 2019, doi: 10.1016/j.pharep.2019.07.002.
  44.  W. Widarti and N. Nurqaidah, “Analisis Kadar Serum Glutamic Pyruvic Transaminase (Sgpt) Dan Serum Glutamic Oxaloacetic Transaminase (Sgot) Pada Petani Yang Menggunakan Pestisida,” J. Media Anal. Kesehat., vol. 10, no. 1, p. 35, 2019, doi: 10.32382/mak.v10i1.984.
  45.  J. Yang et al., “Oxidative stress and non-alcoholic fatty liver disease: Effects of omega-3 fatty acid supplementation,” Nutrients, vol. 11, no. 4, pp. 1–37, 2019, doi: 10.3390/nu11040872.
  46.  P. M. Rindler, S. M. Plafker, L. I. Szweda, and M. Kinter, “High dietary fat selectively increases catalase expression within cardiac mitochondria,” J. Biol. Chem., vol. 288, no. 3, pp. 1979–1990, 2013, doi: 10.1074/jbc.M112.412890.
  47.  O. O. Ogunrinola, O. O. Fajana, S. N. Olaitan, O. B. Adu, and M. O. Akinola, “Anti-diabetic activity of Ipomoea batatas leaves extract: Effects on hepatic enzymes in alloxan-induced diabetic rats,” Res. J. Med. Plant, vol. 9, no. 5, pp. 227–233, 2015, doi: 10.3923/rjmp.2015.227.233.
  48.  S. Pal, S. Gautam, A. Mishra, R. Maurya, and A. K. Srivastava, “Antihyperglycemic and antidyslipidemic potential of Ipomoea batatas leaves in validated diabetic animal models,” Int. J. Pharm. Pharm. Sci., vol. 7, no. 7, pp. 176–186, 2015.
  49. Madasamy M, Sahayaraj K, Sayed SM, Al-Shuraym LA, Selvaraj P, El-Arnaouty SA, Madasamy K. Insecticidal Mechanism of Botanical Crude Extracts and Their Silver Nanoliquids on Phenacoccus solenopsis. Toxics. 2023 Mar 25;11(4):305. doi: 10.3390/toxics11040305. PMID: 37112532; PMCID: PMC10145954.
  50. Fatima N, Rahman MM, Khan MA, Fu J. A review on Ipomoea carnea: pharmacology, toxicology, and phytochemistry. Journal of Complementary and Integrative Medicine. 2014 Jun 1;11(2):55-62
  51. Suresh K, Singh RK. Anti-hepatotoxic and antioxidant influence of Ipomoea carnea against anti-tubercular drug-induced acute hepatopathy in experimental rodents. J Coast Life Med. 2013;1:293-9.
  52. Ferreira AM, Marques da Silva P. Defining the place of ezetimibe/atorvastatin in the management of hyperlipidemia. American Journal of Cardiovascular Drugs. 2017 Jun; 17:169-81.

Reference

  1. Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. The biology and chemistry of hyperlipidemia. Bioorganic & Medicinal Chemistry. 2007 Jul 15;15(14):4674-99.
  2. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Primary care. 2012 Dec 4;40(1):195.
  3. Kaur G, Alam MS, Jabbar Z, Javed K, Athar M. Evaluation of antioxidant activity of Cassia siamea flowers. J Ethnopharmacol 2006; 108: 340-348
  4. Kaesancini AY, Krauss RM. Cardiovascular disease and hyperlipidemia. Current topics of lipid dynamics 1994; 5: 249-251.
  5. Sharma S, Verma A, Teja BV, Shukla P, Mishra PR. Development of stabilized paclitaxel nanocrystals: in vitro and in vivo efficacy studies. Eur J Pharm Sci 2015; 69: 51-60. 8
  6. Araujo FB, Barbosa DS, Hsin CY, Maranhao RC, Abdalla DS. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis 1995; 117: 61-71.
  7. Haraguchi M, Gorniak SL, Ikeda K, Minami Y, Kato A, Watson AA, Nash RJ, Molyneux RJ, Asano N. Alkaloidal components in the poisonous plant, Ipomoea carnea (Convolvulaceae). Journal of Agricultural and Food Chemistry. 2003 Aug 13;51(17):4995-5000.
  8. Schwarz A, Górniak SL, Bernardi MM, Dagli ML, Spinosa HD. Effects of Ipomoea carnea aqueous fraction intake by dams during pregnancy on the physical and neurobehavioral development of rat offspring. Neurotoxicology and teratology. 2003 Sep 1;25(5):615-26.
  9. Rout SK, Kar DM. Sedative, anxiolytic, and anticonvulsant effects of different extracts from the leaves of Ipomoea carnea in experimental animals. Int J Drug Dev Res. 2013 Apr;5(2):232-43
  10. Bachhav KV, Burande MD, Rangari VD, Mehta JK. Effect of aqueous extract of Ipomoea carnea leaf on isolated frog and mouse hearts.
  11. Partridge CR, Johnson CD, Ramos KS. In vitro models to evaluate acute and chronic injury to the heart and vascular systems. Toxicology in vitro. 2005 Aug 1;19(5):631-44.
  12. Bachhav KV, Burande MD, Rangari VD, Mehta JK. Effect of aqueous extract of Ipomoea carnea leaf on isolated frog and mouse heart
  13. Kumar V, Ahmed D, Gupta PS, Anwar F, Mujeeb M. Antidiabetic, antioxidant, and antihyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin-induced diabetic rats. BMC Complement Altern Med 201; 13: 222.
  14. Sahu K, Kohli S. QUALITATIVE PHYTOCHEMICAL SCREENING OF LEAVES AND STEM OF IPOMOEA CARNEA. European Journal of Biomedical. 2016;3(11):208-11.
  15. Maha AA, Ahmed IY, Sakina MY. Evaluation of antidiabetic activity of plants used in western Sudan. Asian pac J Trop biomed 2015; 5: 395-402
  16. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
  17. Locatelli M, Gindro R, Travaglia F, Coïsson JD, Rinaldi M, Arlorio M. Study of the DPPH-scavenging activity: Development of free software for the correct interpretation of data. Food chemistry. 2009 Jun 1;114(3):889-97
  18. Mishra K, Ojha H, Chaudhury NK. Estimation of antiradical properties of antioxidants using DPPH assay: A critical review and results. Food chemistry. 2012 Feb 15;130(4):1036-43.
  19. . Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox biology. 2017 Apr 1;11:613-9.
  20. Fernando CD, Soysa P. Optimized enzymatic colorimetric assay for determination of hydrogen peroxide (H?O?) scavenging activity of plant extracts. MethodsX. 2015 Jan 1;2:283-91.
  21. Khatiwora E, Adsul VB, Kulkarni MM, Deshpande NR, Kashalkar RV. Spectroscopic determination of total phenol and flavonoid contents of Ipomoea carnea. International Journal of ChemTech Research. 2010 Jul;2(3):1698-701.
  22. Blank B, Pfeiffer FR, Greenberg CM, and Kerwin JF. Thyromimetics II: The synthesis and hypercholesterolemic activity of some b-dimethylaminoethyl esters of thyroalkanoic acids. J Med Chem 1963; 6: 560-563
  23. Pande VV, Dubey S. Antihyperlipidemic activity of Sphaeranthus indicus on atherogenic diet-induced hyperlipidemia in rats. Int J Green Pharm 2009; 3: 159–161.
  24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 197; 18: 499-502
  25. Schulpis K, Karikas GA. Serum cholesterol and triglyceride distribution in 7767 school-aged Greek children. Pediatrics 1998; 101: 861-864.
  26. Z. Kmiec, “J.A. Kiernan. Histological and Histochemical Methods: Theory and Practice. 5th edition, Scion Publishing, 2015, 571 pp.,” Folia Histochem. Cytobiol., vol. 54, no. 1, pp. 58–59, 2016, doi: 10.5603/fhc.a2016.0007.
  27. K. M. Gadde, C. K. Martin, H. R. Berthoud, and S. B. Heymsfield, “Obesity: Pathophysiology and Management,” J. Am. Coll. Cardiol., vol. 71, no. 1, pp. 69–84, 2018, doi: 10.1016/j.jacc.2017.11.011.
  28.  F. Barkas, T. Nomikos, E. Liberopoulos, and D. Panagiotakos, “Diet and cardiovascular disease risk among individuals with familial hypercholesterolemia: Systematic review and meta-analysis,” Nutrients, vol. 12, no. 8, pp. 1–22, 2020, doi: 10.3390/nu12082436.
  29.  S. Parasuraman and L. E. Wen, “Animal Model for Obesity—An Overview,” Syst. Rev. Pharm., vol. 6, no. 1, pp. 9–12, 2015.
  30.  J. H. H. Al-awadi, “Hypothyroidism and High Fat Diet Could Accelerate Obesity and Aggravate Inflammation in Albino Rats,” J. Biol., no. September, pp. 1–14, 2016.
  31.  S. Singh, V. Panda, S. Sudhamani, and P. Dande, “Protective effect of a polyherbal bioactive fraction in propylthiouracil-induced thyroid toxicity in rats by modulation of the hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes,” Toxicol. Reports, vol. 7, no. July 2019, pp. 730–742, 2020, doi: 10.1016/j.toxrep.2020.06.002.
  32. K. Sikder, S. K. Shukla, N. Patel, H. Singh, and K. Rafiq, “High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR-γ,” Cell. Physiol. Biochem., vol. 48, no. 3, pp. 1317–1331, 2018, doi: 10.1159/000492091.
  33.  H. Sun, T. Mu, L. Xi, M. Zhang, and J. Chen, “Sweet potato (Ipomoea batatas L.) leaves as nutritional and functional foods,” Food Chem., vol. 156, pp. 380–389, Aug. 2014, doi: 10.1016/j.foodchem.2014.01.079.
  34. D. F. Coelho et al., “Effect of high-fat diets on body composition, lipid metabolism, and insulin sensitivity, and the role of exercise on these parameters,” Brazilian J. Med. Biol. Res., vol. 44, no. 10, pp. 966–972, Oct. 2011, doi: 10.1590/S0100-879X2011007500107.
  35. M. A. Al Mamun et al., “High carbohydrate high fat diet induced hepatic steatosis and dyslipidemia were ameliorated by psidium guajava leaf powder supplementation in rats,” Evidence-based Complement. Altern. Med., vol. 2019, pp. 1–12, 2019, doi: 10.1155/2019/1897237.
  36.  C. Artha, A. Mustika, and S. W. Sulistyawati, “Singawalang Leaf Extract Effects on LDL Levels of Hypercholesterolemic Male Rats,” e-Journal Kedokt. Indones., vol. 5, no. 2, pp. 105–109, 2017.
  37. Xie JH, Jin ML, Morris GA, Zha XQ, Chen HQ, Yi Y, Li JE, Wang ZJ, Gao J, Nie SP, Shang P, Xie MY. Advances on Bioactive Polysaccharides from Medicinal Plants. Crit Rev Food Sci Nutr. 2016 Jul 29;56 Suppl 1:S60-84. doi: 10.1080/10408398.2015.1069255. PMID: 26463231.
  38. N. Mahfudh and N. Ikarini, “In vivo effect of sub-chronic administration of ethanol extract of Rosella (Hibiscus sabdariffa L.) calyx on total blood cholesterol, triglyceride level, and heart histopathologic profile,” Int. Food Res. J., vol. 25, no. 3, pp. 1253–1257, 2018.
  39.  S. Hue, A. N. Boyce, and C. Somasundram, “Comparative Study on the Antioxidant Activity of Leaf Extract and Carotenoids Extract from Ipomoea batatas var. Oren (Sweetpotato) Leaves,” Int. J. Nutr. Food Eng., vol. 5, no. 10, pp. 604–607, 2011.
  40.  R. N. I. Siregar, “The Effect of Eugenia polyantha Extract on LDL,” J. Major., vol. 4, no. 5, pp. 85–92, 2015.
  41.  F. D. Lairin, D. Lyrawati, and S. Soeharto, “Ekstrak Daging Putih Semangka (Citrulus vulgaris) Menurunkan Kolesterol Total dan Aktivitas Hidroksi-Metilglutaril-KoA Reduktase Tikus Hiperkolesterolemia,” J. Kedokt. Brawijaya, vol. 29, no. 2, pp. 104–109, 2016, doi: 10.21776/ub.jkb.2016.029.02.2.
  42. A. G. Elfadhl, M. K. Sabahelkhier, M. Y. Rayan, M. O. Daa, A. H. Nagla, and S. B. Israa, “Effect of Tannin and Plant Tannins on Some Organs and Physic-Chemical Characters of Diabetic Wistar,” Int. J. Adv. Res., vol. 1, no. 10, pp. 165–170, 2013.
  43.  D. Kumar, D. K. Dwivedi, M. Lahkar, and A. Jangra, “Hepatoprotective potential of 7,8-Dihydroxyflavone against alcohol and high-fat diet induced liver toxicity via attenuation of oxido-nitrosative stress and NF-κB activation,” Pharmacol. Reports, vol. 71, no. 6, pp. 1235–1243, Dec. 2019, doi: 10.1016/j.pharep.2019.07.002.
  44.  W. Widarti and N. Nurqaidah, “Analisis Kadar Serum Glutamic Pyruvic Transaminase (Sgpt) Dan Serum Glutamic Oxaloacetic Transaminase (Sgot) Pada Petani Yang Menggunakan Pestisida,” J. Media Anal. Kesehat., vol. 10, no. 1, p. 35, 2019, doi: 10.32382/mak.v10i1.984.
  45.  J. Yang et al., “Oxidative stress and non-alcoholic fatty liver disease: Effects of omega-3 fatty acid supplementation,” Nutrients, vol. 11, no. 4, pp. 1–37, 2019, doi: 10.3390/nu11040872.
  46.  P. M. Rindler, S. M. Plafker, L. I. Szweda, and M. Kinter, “High dietary fat selectively increases catalase expression within cardiac mitochondria,” J. Biol. Chem., vol. 288, no. 3, pp. 1979–1990, 2013, doi: 10.1074/jbc.M112.412890.
  47.  O. O. Ogunrinola, O. O. Fajana, S. N. Olaitan, O. B. Adu, and M. O. Akinola, “Anti-diabetic activity of Ipomoea batatas leaves extract: Effects on hepatic enzymes in alloxan-induced diabetic rats,” Res. J. Med. Plant, vol. 9, no. 5, pp. 227–233, 2015, doi: 10.3923/rjmp.2015.227.233.
  48.  S. Pal, S. Gautam, A. Mishra, R. Maurya, and A. K. Srivastava, “Antihyperglycemic and antidyslipidemic potential of Ipomoea batatas leaves in validated diabetic animal models,” Int. J. Pharm. Pharm. Sci., vol. 7, no. 7, pp. 176–186, 2015.
  49. Madasamy M, Sahayaraj K, Sayed SM, Al-Shuraym LA, Selvaraj P, El-Arnaouty SA, Madasamy K. Insecticidal Mechanism of Botanical Crude Extracts and Their Silver Nanoliquids on Phenacoccus solenopsis. Toxics. 2023 Mar 25;11(4):305. doi: 10.3390/toxics11040305. PMID: 37112532; PMCID: PMC10145954.
  50. Fatima N, Rahman MM, Khan MA, Fu J. A review on Ipomoea carnea: pharmacology, toxicology, and phytochemistry. Journal of Complementary and Integrative Medicine. 2014 Jun 1;11(2):55-62
  51. Suresh K, Singh RK. Anti-hepatotoxic and antioxidant influence of Ipomoea carnea against anti-tubercular drug-induced acute hepatopathy in experimental rodents. J Coast Life Med. 2013;1:293-9.
  52. Ferreira AM, Marques da Silva P. Defining the place of ezetimibe/atorvastatin in the management of hyperlipidemia. American Journal of Cardiovascular Drugs. 2017 Jun; 17:169-81.

Photo
Gulshan Athbhaiya
Corresponding author

.

Photo
Dron Kumar Sahu
Co-author

.

Photo
Laxmi Athbhaiya
Co-author

.

Laxmi Athbhaiya, Dron Kumar Sahu, Gulshan Athbhaiya*, Evaluation of In vitro Antioxidant and In vivo Antihyperlipidemic & Hepatoprotective Activities of ethanol Extract of Ipomoea Carnea Leaf, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 995-1010. https://doi.org/10.5281/zenodo.15834336

More related articles
Formulation And Evaluation of Spanlastic Gel Conta...
Vaishnavi Krishna, Janavi M., Nirmala P., Lakshmi S. T., ...
A Study on Evaluation of Knowledge, Attitude, And ...
Dr. Shivaraj D. R., Praful Wadekar, Prajwal R., Premakumari T., S...
Design and Evaluation of Solid Lipid Nanoparticles...
Sairaj Ingle, Faisal Sheikh, A. Gattani, ...
Styling Nature: A Comprehensive Review and Experimental Evaluation of Polyherbal...
Sughosh Upasani, Harshali Borase, Neha Bhilane, Manoj Girase , ...
Development And Evaluation Luliconazole Embedded Transungual (Nail) Patches for ...
K.M. Manjanna, G. Shiva Krishna, Mohammed Azharuddin, G. Govinda Reddy, ...
No-Rinse Body Wash: Formulation, Evaluation, and Efficacy for Water-Limited Use...
Katrin Mae Ortega, Mikyla A. Candava, Krystle A. Abrau, Marcus Daryl C. Antonio, Hannah Noreen C. Ba...
Related Articles
A Review On: Coffee Bean-Based Herbal Face Scrub Formation and Evaluation...
Dikshita Valvi, Amol Gayke, Tejas Zond, Sakshi Jadhav, Snehal Mate, ...
In-Vitro In Vivo Corelation...
Avhad Atul, Dr. Shivraj Jadhav, Mayur Bhamare, Dr. Sunil Mahajan, ...
Formulation and Evaluation of Aloe Vera Herbal Soap ...
Swapnil Talekar , Sachin Bhalekar , Sainath Gadekar , Pranay Chavan , Tejas Satpute , ...
Experimental and Computational Evaluation of Garlic (Allium Sativum) for its Pot...
Pankaj Kore, Pratiksha Parit, Saloni Pawar, Shital Vadar, Tushar Kawale, ...
Formulation And Evaluation of Spanlastic Gel Containing Econazole Nitrate...
Vaishnavi Krishna, Janavi M., Nirmala P., Lakshmi S. T., ...
More related articles
Formulation And Evaluation of Spanlastic Gel Containing Econazole Nitrate...
Vaishnavi Krishna, Janavi M., Nirmala P., Lakshmi S. T., ...
A Study on Evaluation of Knowledge, Attitude, And Practice Toward Medication Adh...
Dr. Shivaraj D. R., Praful Wadekar, Prajwal R., Premakumari T., Sahana H. C., Sahana M., ...
Formulation And Evaluation of Spanlastic Gel Containing Econazole Nitrate...
Vaishnavi Krishna, Janavi M., Nirmala P., Lakshmi S. T., ...
A Study on Evaluation of Knowledge, Attitude, And Practice Toward Medication Adh...
Dr. Shivaraj D. R., Praful Wadekar, Prajwal R., Premakumari T., Sahana H. C., Sahana M., ...